The Pediatrics Oncology Program of the University of Wisconsin is a component of the UW Comprehensive Cancer Center (UWCCC) and a founding member of CCG. We house the CCG Biotherapeutics Resource Laboratory, directed by Dr. Paul, and participate in CCG Phase I and BMT trials as an approved center. Dr. Sondel also directs UWCCC Biotherapy Program and his experience with biologic therapeutics has lead directly to CCG trials. U.W.'s primary contribution to CCG is in the area of scientific leadership. Dr. Gaynon served on the CCG Executive Committee as member- at-large (term 91-92), and serves on the Publications Committee as chairman, on the ALL Strategy Group as a vice chairman, and on the Steering Committee of the New Agents Committee. Dr Sondel serves as chairman for Immunology/Biologic Therapy for the New Agents Committee and as Director of the CCG Biologic Therapeutics Resource Laboratory. Drs. Minesh Mehta and Pat Turski serve on the Brain Tumor Strategy Group. Dr. Tim Kinsella has been appointed to the Local Tumor Control Strategy Group and Bone Tumor Strategy. U.W. investigators hold 47 appointments to various CCG committees, including 3 vice chairmanships, and 8 chairmanships. Since the last competitive renewal, we have added as affiliates the University of Illinois in Rockford and the Dean Clinic/St. Mary's Hospital in Madison, Wisconsin. Between 8/1/91 and 7/31/92, we obtained 40 accruals on CCG studies including 10 from our Rockford affiliate and 4 from our St. Mary's affiliate. Twenty-four patients were enrolled in therapeutic studies and 19 in non-therapeutic studies. We performed 7 bone marrow transplants (3 auto/4 allo year-end 12/31/93). In addition, we enrolled 3 patients on Dr. Jim Miser's Osteosarcoma Trial which has served as the basis for the upcoming CCG phase III trial. We have 300 patients alive and in follow-up.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Cooperative Clinical Research--Cooperative Agreements (U10)
Project #
Application #
Study Section
Cancer Clinical Investigation Review Committee (CCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Wisconsin Madison
Schools of Medicine
United States
Zip Code
Shamberger, Robert C; LaQuaglia, Michael P; Gebhardt, Mark C et al. (2003) Ewing sarcoma/primitive neuroectodermal tumor of the chest wall: impact of initial versus delayed resection on tumor margins, survival, and use of radiation therapy. Ann Surg 238:563-7; discussion 567-8
Davies, Stella M; Bhatia, Smita; Ross, Julie A et al. (2002) Glutathione S-transferase genotypes, genetic susceptibility, and outcome of therapy in childhood acute lymphoblastic leukemia. Blood 100:67-71
Wells, Robert J; Reid, Joel M; Ames, Matthew M et al. (2002) Phase I trial of cisplatin and topotecan in children with recurrent solid tumors: Children's Cancer Group Study 0942. J Pediatr Hematol Oncol 24:89-93
Lange, Beverly J; Bostrom, Bruce C; Cherlow, Joel M et al. (2002) Double-delayed intensification improves event-free survival for children with intermediate-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group. Blood 99:825-33
Ou, Shu Xiao; Han, Dehui; Severson, Richard K et al. (2002) Birth characteristics, maternal reproductive history, hormone use during pregnancy, and risk of childhood acute lymphocytic leukemia by immunophenotype (United States). Cancer Causes Control 13:15-25
Cairo, M S; Krailo, M D; Morse, M et al. (2002) Long-term follow-up of short intensive multiagent chemotherapy without high-dose methotrexate ('Orange') in children with advanced non-lymphoblastic non-Hodgkin's lymphoma: a children's cancer group report. Leukemia 16:594-600
Wells, R J; Arthur, D C; Srivastava, A et al. (2002) Prognostic variables in newly diagnosed children and adolescents with acute myeloid leukemia: Children's Cancer Group Study 213. Leukemia 16:601-7
Cooper, R; Khakoo, Y; Matthay, K K et al. (2001) Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: histopathologic features-a report from the Children's Cancer Group. Med Pediatr Oncol 36:623-9
Teplitzky, S R; Kiefer, T L; Cheng, Q et al. (2001) Chemoprevention of NMU-induced rat mammary carcinoma with the combination of melatonin and 9-cis-retinoic acid. Cancer Lett 168:155-63
Kammen, B F; Matthay, K K; Pacharn, P et al. (2001) Pulmonary metastases at diagnosis of neuroblastoma in pediatric patients: CT findings and prognosis. AJR Am J Roentgenol 176:755-9

Showing the most recent 10 out of 27 publications